Menu
FDA · Drug recall

Minocycline Hydrochloride Capsules USP…

April 13, 2016 Class III

Date
April 13, 2016
Risk class
Class III (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences)
Status
Terminated
Filed by
Apace KY LLC
Product
Minocycline Hydrochloride Capsules USP, 100 mg*, 30 Capsules (3 x 10) Unit Dose blisters (NDC 50268-569-11, barcode 5026856911) per carton (NDC 50268-569-13, barcode 5026856913), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478.
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.
Distribution pattern
All product was shipped to KY and further distributed Nationwide
Quantity
291 cartons
Codes and lots
Outer Cases and Cartons Lot #: 13650, EXP 06/2017; Blisters Lot #: 13560, EXP 06/2017
Recall started
Feb. 12, 2016
Recall number
D-0811-2016

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0811-2016. The agency record governs; check it and the company before acting.

Report a mistake on this page